Hyponatremia in Patients Admitted to a Coronary Care Unit
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Calculation of osmolal gap in plasma and urine samples from patients after acute myocardial infarction was carried out to see whether changes in these variables support the concept of a "sick-cell" mechanism being responsible for the hyponatremia associated with acute myocardial infarction. Some supportive evidence was found on the first day after admission but, overall, the evidence was not convincing.
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Systemic metabolic changes follow acute myocardial infarction including increased plasma concentrations of catecholamines, cortisol, renin, angiotensin
II, and arginine vasopressin (AVP) (1-6).
Flear and Hilton (7) showed that hyponatremia is common in patients with confirmed AMI and that the degree of illness correlates roughly with the decrease in plasma sodium. The hyponatremia is transient, being greatest on day 3 or 4 after admission, then returning towards first-day plasma sodium concentrations by day 6 or 7. The average decrease in plasma sodium is about 5 mmol/L in the most severely affected group, with smaller changes in the less-affected patients. Flear increase in cell-membrane permeability (i.e., the "sick-cell syndrome") or to a net gain of water caused by a stress-related sustained secretion of AVP.
We undertook this study to seek evidence for the involvement of the sick-cell syndrome mechanisms in the pathogenesis of hyponatremia in AMI, in particular by measurement of osmolal gaps in plasma and urine.
Patients and Methods
Patients
We studied 57 patients who were admitted with chest pain and suspected AMI; patients diagnosed as having other serious illnesses were not included. The patients studied received therapy as indicated clinically. There were no restrictions on oral fluid intake. Each patient was assessed clinically and placed into one of three groups according to the following criteria: #{149} Heparinized blood samples and an untimed sample of urine were obtained on the morning of days 1,2, and 3 after admission.
The first available morning urine sample was collected. Normally, this was the overnight pre-breakfast urine, but if this specimen was not obtained, then the next available specimen was sent to the laboratory. A preliminary study of 26 patients showed that there were no significant differences in urine sodium, potassium, chloride, urea, creatinine, osmolality, or osmolal gap between the preprandial overnight urine and the second morning urine specimens. All urine samples were tested for glucose with Clinistix-anypatientswith a positive urine glucose were not included in the study, because of an effect of urine glucose on urine osmolal gap comparisons (&.-1O).
Methods
Plasma sodium and potassium were measured by flame emission spectrophotometry (IL 543 spectrometer; Instrumentation Laboratory, Lexington, MA). Total CO2 was measured by generation of carbon dioxide with acid and diffusion into sodium bicarbonate with phenolphthalein as a pH-change indicator (11) . Urea was measured by reaction with diacetyl monoxime in the presence of thiosemicarbaside under acid conditions (12) , and creatinine was measured by the Jaff#{233} reaction (13) . Chloride was measured electrometrically with a Corning 925 chloride meter (Corning Medical, Medfield, MA). Osmolality was measured by freezing-point osmometry (Roebling osmometer). Phosphate was measured by reaction with molybdate and reduction of the resulting phosphomolybdic acid to molybdenum blue (14) . Plasma glucose was measured with a glucose-selective electrode (Model 23AM glucose analyzer; Yellow Springs Instrument Co., Yellow Springs, OH). Sodium, potassium, chloride, osmolality, urea, creatinine, and phosphate were measured in urine by the same methods as used for plasma, with prior dilution with distilled water where appropriate. Urine ammonia was measured by the Berthelot indophenol method (15) .
Osmolal gaps were calculated as measured osmolality (mmollkg) minus a linear function of some of the measured concentrations of sodium, potassium, glucose, urea, and chloride (all measured in mmol/L). As in previous publications (8, 16) , the units of osmolal gap were called mmollkg. The osmolal gap in plasma was calculated as follows: measured osmolality -(2Na + 2K + glucose + urea) (16) . We determined the reference range to be +2 to -16 mmol/kg in pre-surgical blood samples from 30 patients undergoing minor surgery.
The osmolal gap in urine was measured as follows: measured osmolality -(Na + K + Cl + urea + 24) x 1.044 (8) . The reference range was determined as -58 to + 58 mmol/kg (8) . For the reference (normal) group of people, the osmolal gap was not correlated to the osmolality of the urine (r = 0.085, P >0.1).
Urinary excretion of sodium per liter of glomerular filtrate was calculated as follows: Na(urine)
x creatinine-(plasma)/creatinine(urine), where all the concentrations are in mmol/L. Potassium excretions were calculated in the same way.
Means of two sets of data were compared by a t-test in which one does not assume equal variances in the two sets of data (17) . Correlations between sets of data were analyzed by the least-squares method of linear-regression analysis(18).
Plasma and urine results. The plasma sodium decreased most markedly in Group 3 (Figure l#{192} ), whereas the urine sodium concentrations were not significantly different between the groups (Figure iB) .
The plasma potassium values for Groups 2 and 3 tended to be higher than those for Group 1 on day 1, then decreased from day 1 to day 3 for these groups ( Figure 1C) . The urine potassium concentrations were higher in Groups 2 and 3 than in Group ion day 1; thereafter, they decreased to the same values as Group 1 (Figure iD) .
Although the plasma osmolal gaps were not increased, and were similarin all groups (Figure IE) , the urine osmolal gaps in groups 2 and 3 exceeded those in Group 1 and the upper reference limit on day 1 (Figure iF) . The urine osmolal gaps in Groups 2 and 3 decreased into the reference range on days 2 and 3, but the Group 3 mean value was still significantly higher than the Group 1 value on day 3.
The urine osmolalities were also higher in Group 2 and 3 than in Group 1 over the three days, but in all groups the urines were concentrated relative to plasma osmolalities ( Figures   iG and 111) . The urine osmolal gap/osmolality ratios were significantly increased (P <0.05) in Groups 2 and 3 relative to Group 1 on day 1, indicating that the greater osmolal gaps could not be attributed to the urines being more concentrated in Groups 2 and 3 relative to Group 1. This observation was true also for Group 3 relative to Group 1 on day 3.
For all patients, the decrease in plasma sodium from day 1 to day 3 and the value of the plasma sodium on day 3 (the dependent variables) were correlated against all the other variables measured for each of the three days of study. The relevant significant regressions (P of slope <0.05) are shown in Table 1 .
Effect of diuretics and intravenous
dextrose. Diuretics were given to some patients in all groups; intravenous dextrose (mean 2.6 L, SD 1.3 L, over three days) was given to some patients in group 3 only, to administer dobutamine. The effect of these treatments on the dependent variables in the regression analysis was assessed by t-tests. We found no significant differences in these variables between diuretic-treated and untreated patients in any group, nor between dextrose-treated and -untreated patients in Group 3.
Contribution of ammonia, phosphate, and creatinine to osmolal gaps in urine. We analyzed for these analytes in 50 urine samples (which had been stored at -20 #{176}C) known to have increased urine osmolal gaps. For 22 samples with osmolal gaps between + 2 and + 3 SDs of the reference group (59-86 mmollkg), the mean percentage contribution of the sum of the three analytes to the urine osmolal gaps was 82.4% (SD = 27.5). For 28 samples with osmolal gap greater than + 3 5Ds of the reference group (87 mmollkg or greater), the mean percentage contribution of the sum of the three analytes was 63.8% (SD = 18.7). Student's t-test of the difference between the means gave t = 2.84 and P <0.01.
Discussion
The equation for plasma osmolal gap used in this work has been published previously (16) , but the equation for urine osmolal gap was developed for this work (8) . For both equations a calculated osmolality was subtracted from the measured osmolality.
For urine, the calculated osmolality was based on the A B 
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Urea.?(2) -0.409 Urea.,, (3) -0.336 Na, (3) Osm (2) Osm (3) OG (2) Na..(2) Na, (3) 1Jrea ( The decrease in plasma sodium over the three days of study was correlated, weakly, to some potassium variables over days 1 and 2 ( Table 1 ), so that the greater decreases in plasma sodium correlated with higher plasma potassium, potassium excretion, and urine potassium concentration on day 2. Thus, developing hyponatremia may be related to potassium movement from the intracellular fluid to the extracellular fluid, with subsequent excretion in the urine; this could be taken as evidence for the sick-cell concept.
However, the lack of correlation of the plasma sodium on day 3 with any of the potassium indices tends to invalidate the sick-cell concept.
Although we found no increased osmolal gaps in plasma ( Figure 1E ), Groups 2 and 3 on day 1 showed increased osmolal gaps in urine ( Figure 1G ), which could be taken as evidence for sick-cell concept. However, again, the concept was not supported by the lack of correlation of the value of the plasma sodium on day 3 with the osmolal gap in urine.
Also, there was no correlation of the decrease in plasma sodium with the osmolal gap in urine or plasma, although the plasma sodium on day 3 did correlate with the osmolal gap in plasma on day 2 (Table 1) .
In theory (19) , the osmolal gap and potassium data should produce the strongest evidence for the sick-cell mechanism. On this basis, the data in this study have not produced convincing evidence for this mechanism operating in the development of hyponatremia after AM!. if the sick-cell mechanism is operating at all, this study suggests the most likely time is during the first day of the illness.
The other mechanistic possibility is that there is a sustained release of AVP over the three days after AM!; some recent studies (4) (5) (6) 20) support this view.
